Cylex Announces Distribution Partnership with GTI, Inc.Business Editors & Health/Medical Writers BIOWIRE2K COLUMBIA, Md.--(BUSINESS WIRE)--Oct. 8, 2002 Cylex Inc., a privately held, venture-capital backed life science Company, announced today it has entered into a distribution arrangement with GTI GTI Gas Technology Institute GTI Global Taxonomy Initiative GTI Good Time Interval GTI Guelph Turfgrass Institute GTI Green Theme International GTI Gordon Training International GTI Georgia Transportation Institute GTI Group Travel Insurance , Inc., Brookfield, Wisconsin for it's Immune Cell Function Assay into selected HLA HLA human leukocyte antigens. HLA abbr. human leukocyte antigen HLA (human leuckocyte antigen) laboratories in the U.S. and Canada. The assay is used to measure the immune response immune response n. An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes. of patients receiving immunosuppressant immunosuppressant /im·mu·no·sup·pres·sant/ (-sah-pres´ant) an agent capable of suppressing immune responses. im·mu·no·sup·pres·sant n. An agent that suppresses the body's immune response. therapy for organ transplantation The transfer of organs such as the kidneys, heart, or liver from one body to another. The transplantation of human organs has become a common medical procedure. Typical organs transplanted are the kidneys, heart, liver, pancreas, cornea, skin, bones, and lungs. and is the first product cleared by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for measuring global cell-mediated immunity cell-mediated immunity n. Abbr. CMI Immunity resulting from a cell-mediated immune response. Also called cellular immunity. . GTI, Inc., a privately held medical diagnostic manufacturer is a for-profit subsidiary of the Blood Research Institute of the Blood Center of Southeastern Wisconsin. The Company currently manufacturers and sells diagnostic products worldwide to transplantation laboratories. GTI President, Jim Tidey, commented, "We believe the Cylex assay is an excellent product and a perfect fit with GTI's business strategy. We are looking forward to the opportunity to work with Cylex and sell this exciting new product." Cylex's President, Dr. Judith Britz, explained, "GTI is a valuable distribution partner because of GTI's existing customer relationships with outstanding HLA laboratories. Cylex's assay for the assessment of cell-mediated immunity is a natural complement to GTI's transplant monitoring system for HLA antibodies in the management of the transplant recipient." Cylex is a life science Company that manufacturers and develops patented in vitro diagnostic products for the assessment of immunity. These products have utility for physicians treating life-threatening diseases or conditions who seek to optimize therapy through individualized management of patient's immune system, thereby reducing side effects, improving clinical response and quality of life. The Immune Cell Function Assay is intended to be used as an adjunct to post-transplantation drug level monitoring along with other clinical indicators. Cylex's patented platform technology will also provide an innovative approach for measuring immune activity in AIDS and cancer patients, and those with infectious diseases, autoimmune or other immune system disorders. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion